What is KLAC's Value Score?

KLA Corporation - Common Stock (KLAC) has a StockPik Value Score of 56 out of 100 — a mid-range score, indicating moderate value characteristics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is KLAC's Piotroski F-Score?

KLA Corporation - Common Stock (KLAC) has a Piotroski F-Score of 6 out of 9 — a moderate score. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

Is KLAC trading below its Graham Number?

KLAC is currently trading above its Graham Number. The stock price of $1443.21 exceeds the Graham Number of $172.97, meaning it does not meet Graham's criterion for a margin of safety at the current price. The Graham Number is calculated as √(22.5 × EPS × Book Value Per Share) and represents Benjamin Graham's ceiling price for a defensive investor.

What is KLAC's Graham Number?

KLAC's Graham Number is $172.97, calculated using the Benjamin Graham formula √(22.5 × EPS × Book Value per Share). The Graham Number is an estimate of intrinsic value — the maximum price a defensive investor should pay. At the current price of $1,443.21, KLAC is trading 734% above its Graham Number.

What is KLAC's Piotroski F-Score?

KLAC's Piotroski F-Score is 6 out of 9, indicating moderate financial health. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is KLAC (KLA Corporation - Common Stock) undervalued?

KLAC scores 56/100 on StockPik's Value Score, an above-average rating. The stock trades 734% above its Graham Number of $172.97.

What is KLAC's P/E ratio?

KLAC's trailing P/E ratio is 45.3x — an elevated earnings multiple, potentially pricing in high growth expectations. The Healthcare sector average P/E is 25.3x. Compare against other Healthcare stocks in the StockPik screener.

Does KLA Corporation - Common Stock (KLAC) pay a dividend?

Yes, KLAC currently pays a dividend yield of 0.5%. View the full dividend and value analysis on StockPik.

What sector is KLA Corporation - Common Stock (KLAC) in?

KLA Corporation - Common Stock (KLAC) is in the Healthcare sector, specifically in the Optical Instruments & Lenses industry. Compare it against other Healthcare stocks by Value Score, P/E ratio, and Piotroski F-Score on StockPik.

Back to Screener

KLA Corporation - Common Stock (KLAC)

NASDAQ Large Cap

Healthcare › Optical Instruments & Lenses

$1,443.21

Market Cap: $189.2B

Data as of Dec 31, 2025 (TTM)

Price History

Feb 9, 2026 — Mar 30, 2026

Investment Snapshot

Trading 734% above Graham Number — above intrinsic value estimate
Piotroski F-Score 6/9 — moderate financial health
Strong ROE of 76.5% with 33.0% net margin
Revenue growing at 24% annually

KLA Corporation - Common Stock (KLAC) is a Healthcare company operating in Optical Instruments & Lenses, listed on the NASDAQ , with a market capitalisation of $189.2 billion . Key value metrics: P/E ratio 45.3, P/B ratio 34.61, Piotroski F-Score 6 out of 9 (moderate financial health) .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

45.26

P/B Ratio

34.61

EPS

$31.89

Div. Yield

0.5%

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Current vs 5-Year Average

Based on 5 years of SEC filings

Net Margin

—

↑ +2.1pp avg —

Gross Margin

—

↑ +2.1pp avg —

Operating Margin

—

↑ +2.1pp avg —

Return on Equity

—

↑ +2.1pp avg —

Debt / Equity

—

↑ +2.1pp avg —

See How Margins & ROE Have Trended — Try PRO

Revenue & Net Income

Profit Margins

Track Gross, Operating & Net Margins — Try PRO

EPS & Free Cash Flow Per Share

See EPS & Free Cash Flow Trends — Try PRO

Financial Statements

Metric	FY22	FY23	FY24
Revenue	$X.XB	$X.XB	$X.XB
Gross Profit	$X.XB	$X.XB	$X.XB
Operating Income	$X.XB	$X.XB	$X.XB
Net Income	$X.XB	$X.XB	$X.XB
EBITDA	$X.XB	$X.XB	$X.XB
Total Assets	$X.XB	$X.XB	$X.XB
Total Liabilities	$X.XB	$X.XB	$X.XB

Unlock 5 Years of Financials — Start Free Trial

Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

KLA Corporation - Common Stock — Fundamental Analysis Summary

KLA Corporation - Common Stock (KLAC) is currently trading 734% above its Graham Number of $172.97, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 45.3x.

On financial health, KLAC shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 76.5% (sector average: -19.8%), and elevated leverage with a debt-to-equity ratio of 1.21.

StockPik's composite Value Score for KLAC is 56/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

KLAC shows revenue growing at 24% year-over-year, with earnings growing at 47%.

KLAC pays a modest dividend yield of 0.5%.

Top Value Stocks in Healthcare

Symbol	Name	Price	P/E	Score
CYRX	CRYOPORT, INC.	$8.21	4.7	100
CRMD	CORMEDIX INC.	$6.70	3.6	100
CGEN	Compugen Ltd	$2.06	5.5	100
ABEO	ABEONA THERAPEUTICS INC.	$4.82	4.5	100
BDMD	Baird Medical Investment Holdings Limited	$2.01	5.8	100

Browse all Healthcare value stocks →

How is the Value Score calculated?

Read our full methodology →

How is the Graham Number calculated?

Benjamin Graham's intrinsic value formula, worked examples, and how to use it →

KKR — KKR & CO. INC.

Klarna Group plc — KLAR